Insiders · VKTX

Michael Morneau

Officer at Viking Therapeutics, Inc. (VKTX)

Michael Morneau has filed 1 insider report with the SEC since January 2021, as officer at Viking Therapeutics, Inc. (VKTX). The latest filing, on January 19, 2021, reports shares withheld for taxes or exercise price at Viking Therapeutics, Inc. (VKTX).

Filings
1
Companies
1
Bought on market
None
Sold on market
None

Companies where Michael Morneau is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Viking Therapeutics, Inc. logo
VKTX
Viking Therapeutics, Inc.
Officer116,062$24.77Jan 19, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Other insiders at the same companies

Questions about Michael Morneau

What is Michael Morneau's role at Viking Therapeutics, Inc.?
Michael Morneau reports to the SEC as officer at Viking Therapeutics, Inc. (VKTX), according to the latest filing on January 19, 2021.
How many shares does Michael Morneau own?
After the latest filing that states it, Michael Morneau directly owned 116,062 shares of Viking Therapeutics, Inc. (VKTX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Michael Morneau bought or sold stock recently?
No open-market purchases or sales by Michael Morneau are on file. The filings report shares withheld for taxes or exercise price.
How do I get alerts when Michael Morneau files?
Follow Michael Morneau on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Michael Morneau (SEC CIK 0001517780). Totals count each trade once, skipping amendments whose original is on file, from Jan 19, 2021 on. View on SEC EDGAR · Get this as JSON